Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Genetic Studies of Insulin and Diabetes

NCT: NCT00001987 · RECRUITING

NCT IDNCT00001987
StatusRECRUITING
Start Date1976-02-01

Brief Summary

The study will allow researchers to obtain blood, plasma, DNA, and RNA for genetic studies of insulin. There will be a focus on the causes of insulin resistance and diabetes mellitus. Insulin is a hormone found in the body that controls the level of sugar in the blood. Insulin resistance refers to conditions like diabetes when insulin does not work properly. In this study researchers would like to compare patients with diabetes and other forms of insulin resistance to normal individuals. The study will investigate how insulin attaches to cells. Researchers will take 4 to 6 ounces (100-150 ml) of blood from adult patients and may request up to 12 ounces (one unit) of blood if necessary. Skin samples may be taken for a biopsy if further genetic testing is necessary. In addition some patients may be asked not to eat for up to 72 hours prior to testing....

Frequently Asked Questions

What is Genetic Studies of Insulin and Diabetes?

Genetic Studies of Insulin and Diabetes is a clinical trial registered under NCT00001987. Current status: RECRUITING.

What is the status of NCT00001987?

The current status of NCT00001987 (Genetic Studies of Insulin and Diabetes) is: RECRUITING.

When did Genetic Studies of Insulin and Diabetes start?

Genetic Studies of Insulin and Diabetes started on 1976-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.